Intensive lipid lowering with atorvastatin reduces progression of coronary atherosclerosis, as measured by intravascular ultrasound

Law, 2002, Risk factor thresholds, BMJ, 324, 1570, 10.1136/bmj.324.7353.1570 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 2004, Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions, Lancet, 363, 757, 10.1016/S0140-6736(04)15690-0 Nissen, 2004, for the REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial, JAMA, 291, 1071, 10.1001/jama.291.9.1071 Cannon, 2004, for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Davignon J. Beneficial cardiovascular pleitropic effect of statins. Circulation 2004; 109[suppl III]:III-39-III-43. Law, 2003, Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke, BMJ, 326, 1423, 10.1136/bmj.326.7404.1423 Vale, 2003, Coaching Patients On Achieving Cardiovascular Health (COACH) A Multicenter Randomized Trial in Patients with Coronary Heart Disease, Arch Intern Med, 163, 2775, 10.1001/archinte.163.22.2775